| Primary |
| Hypertension |
23.9% |
| Pneumonia |
11.8% |
| Thrombosis Prophylaxis |
7.1% |
| Urinary Tract Infection |
5.5% |
| Pain |
5.1% |
| Arthritis |
4.7% |
| Hypersensitivity |
3.9% |
| Sinusitis |
3.9% |
| Endocarditis Prophylaxis |
3.5% |
| Glomerulonephritis |
3.5% |
| Prophylaxis |
3.5% |
| Pneumonia Aspiration |
3.1% |
| Hypothyroidism |
2.7% |
| Infection |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Skin Infection |
2.7% |
| Bacterial Infection |
2.4% |
| Cellulitis |
2.4% |
| Pyrexia |
2.4% |
| Tonsillitis |
2.4% |
|
| Drug Interaction |
7.7% |
| Enterocolitis Haemorrhagic |
7.7% |
| Hepatitis Acute |
7.7% |
| Pseudomembranous Colitis |
7.7% |
| Septic Shock |
7.7% |
| Vomiting |
7.7% |
| Clostridial Infection |
4.6% |
| Drug Ineffective |
4.6% |
| Hallucination |
4.6% |
| Klebsiella Infection |
4.6% |
| Linear Iga Disease |
4.6% |
| Rash |
4.6% |
| Transaminases Increased |
4.6% |
| Anaphylactic Reaction |
3.1% |
| Angioedema |
3.1% |
| Cardio-respiratory Arrest |
3.1% |
| Clostridium Difficile Colitis |
3.1% |
| Culture Stool Positive |
3.1% |
| Diarrhoea Haemorrhagic |
3.1% |
| Enterocolitis Infectious |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
13.0% |
| Product Used For Unknown Indication |
8.4% |
| Pneumonia |
8.2% |
| Bacteraemia |
7.7% |
| Type 2 Diabetes Mellitus |
5.4% |
| Bacterial Infection |
5.1% |
| Bronchopneumonia |
5.1% |
| Pyrexia |
3.8% |
| Thrombosis Prophylaxis |
3.3% |
| Arthritis |
3.1% |
| Prophylaxis |
3.1% |
| Tooth Abscess |
3.1% |
| Sepsis |
2.8% |
| Hypersensitivity |
2.6% |
| Infection Prophylaxis |
2.6% |
| Glomerulonephritis |
2.3% |
| Glaucoma |
2.0% |
| Pain |
2.0% |
| Urinary Tract Infection |
1.8% |
|
| Toxic Epidermal Necrolysis |
14.0% |
| Hepatitis Acute |
12.3% |
| Acute Generalised Exanthematous Pustulosis |
7.0% |
| Stevens-johnson Syndrome |
7.0% |
| Urinary Tract Infection Enterococcal |
7.0% |
| Pneumonia |
5.3% |
| Rash Maculo-papular |
5.3% |
| Rash Morbilliform |
5.3% |
| Vomiting |
5.3% |
| Enterocolitis Infectious |
3.5% |
| Hyperglycaemia |
3.5% |
| Pancytopenia |
3.5% |
| Phimosis |
3.5% |
| Pneumonia Haemophilus |
3.5% |
| Pseudomembranous Colitis |
3.5% |
| Skin Ulcer |
3.5% |
| Blood Sodium Decreased |
1.8% |
| Cellulitis |
1.8% |
| Diplopia |
1.8% |
| Drug Resistance |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.9% |
| Drug Use For Unknown Indication |
11.4% |
| Prophylaxis |
8.9% |
| Renal Transplant |
8.2% |
| Hypertension |
6.6% |
| Prophylaxis Against Transplant Rejection |
6.1% |
| Non-small Cell Lung Cancer |
4.5% |
| Pain |
4.3% |
| Rheumatoid Arthritis |
3.9% |
| Acute Myeloid Leukaemia |
3.4% |
| Diabetes Mellitus |
3.4% |
| Ovarian Abscess |
3.4% |
| Anaesthesia |
3.2% |
| Acinetobacter Infection |
3.0% |
| Infection |
2.5% |
| Staphylococcal Infection |
2.5% |
| Dermatomyositis |
2.3% |
| Pneumonia |
2.3% |
| Surgery |
2.3% |
| Epilepsy |
2.0% |
|
| Wound Infection |
11.1% |
| Cytomegalovirus Colitis |
6.9% |
| Pyrexia |
6.9% |
| Sepsis |
6.9% |
| Therapeutic Agent Toxicity |
6.9% |
| Colectomy |
5.6% |
| Pneumonia |
5.6% |
| Psychotic Disorder |
5.6% |
| Renal Cell Carcinoma |
5.6% |
| Cerebral Infarction |
4.2% |
| Pseudomembranous Colitis |
4.2% |
| Renal Failure |
4.2% |
| Thrombocytopenia |
4.2% |
| Tracheobronchitis |
4.2% |
| Urinary Tract Infection |
4.2% |
| Cholecystitis |
2.8% |
| Drug Ineffective |
2.8% |
| Gastroenteritis Rotavirus |
2.8% |
| General Physical Health Deterioration |
2.8% |
| Lymphopenia |
2.8% |
|
| Interacting |
| Hypertension |
19.5% |
| Ischaemic Heart Disease Prophylaxis |
19.5% |
| Urinary Tract Infection |
17.1% |
| Helicobacter Infection |
14.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
9.8% |
| Cardiac Failure |
4.9% |
| Atrial Fibrillation |
2.4% |
| Gastritis |
2.4% |
| Headache |
2.4% |
| Nausea |
2.4% |
| Pneumonia |
2.4% |
| Pneumonia Staphylococcal |
2.4% |
|
| Drug Interaction |
66.7% |
| Gastrointestinal Haemorrhage |
16.7% |
| Platelet Count Decreased |
16.7% |
|
